EME Medical
EME Medical › Drug encyclopedia

💊 Semaglutide (Ozempic)

💊 GLP-1 Receptor Agonist (Glucagon-like Peptide-1 agonist)

Ozempic (semaglutide) is a once-weekly subcutaneous injection and a GLP-1 receptor agonist. It is used in adults with type 2 diabetes to improve blood sugar control and, in specific groups, to reduce the risk of certain heart and kidney complications. It is available by prescription only.

🏷️ Brands: Ozempic💉 Subcutaneous📋 Prescription only
In Arabic: سيماجلوتايد (أوزيمبيك)
Chemical structure of Semaglutide
ⓘ

✅ What it is used for

🧪 Active ingredient

The active ingredient is semaglutide, a GLP-1 analogue that binds to and activates the GLP-1 receptor. It stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, and slightly delays gastric emptying after meals.

🌿 Benefits

📝 How to use

💊 Dosage forms

⚠️ Common side effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Constipation

🚨 Serious — seek medical help

  • Thyroid C-cell tumors (boxed warning: seen in rodents; human relevance unknown); symptoms include a neck mass, difficulty swallowing, shortness of breath, or persistent hoarseness
  • Acute pancreatitis
  • Diabetic retinopathy complications
  • Severe hypoglycemia when used with insulin or sulfonylureas
  • Acute kidney injury due to volume depletion
  • Severe gastrointestinal reactions
  • Serious hypersensitivity reactions (anaphylaxis, angioedema)
  • Acute gallbladder disease (gallstones or cholecystitis)
  • Pulmonary aspiration during general anesthesia or deep sedation

⛔ Do not use if

❗ Warnings & precautions

🔄 Drug interactions

🤰 Pregnancy

Data in pregnant women are limited, and animal studies suggest potential risk to the fetus. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. It should be discontinued at least 2 months before a planned pregnancy because of its long washout period. Talk to your doctor before planning pregnancy.

🍼 Breastfeeding

The label text provided does not include information on use during breastfeeding. Consult your doctor before using it.

🧒 Children

Safety and efficacy of Ozempic have not been established in pediatric patients.

👴 Older adults

No overall differences in safety or efficacy were detected between older and younger patients, but greater sensitivity in some older individuals cannot be ruled out.

🌡️ Storage

Storage conditions are not included in the label text provided. Follow the instructions in the package leaflet and your pharmacist's advice.

⏰ Missed dose

If a dose is missed, inject it as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and take the next dose on the regularly scheduled day, then resume the usual weekly schedule. The day of weekly dosing can be changed if at least 2 days (>48 hours) separate two doses.

🆘 Overdose

In case of overdose, supportive treatment is given according to symptoms. Contact a poison control center or seek emergency care immediately. A prolonged period of observation and treatment may be needed because the drug's half-life is approximately 1 week.

💰 Price & brands in your area

🏛️ Official price in Palestine — Ministry of Health price list:

ProductCompanyPackPrice
OZEMPIC 0.25MG/0.19ML - PFP
SEMAGLUTIDE 1.34MG/ML
MSS1 PFP388 ₪
OZEMPIC 0.5MG/0.37ML - PFP
SEMAGLUTIDE 1.34MG/ML
MSS1 PFP388 ₪
OZEMPIC 1MG/0.74ML - PFP
SEMAGLUTIDE 1.34MG/ML
MSS1 PFP401 ₪
Source: pharmacy.moh.ps · list updated: 2026-11-10

📍 Find the nearest pharmacy

Your location is used only in your browser to show nearby pharmacies — we don't store it.

Open in Google Maps

👨‍⚕️ For healthcare professionals

Mechanism of action

GLP-1 receptor agonist with 94% sequence homology to human GLP-1. Stimulates insulin secretion and lowers glucagon secretion in a glucose-dependent manner, with a minor delay in early postprandial gastric emptying. Albumin binding reduces renal clearance and protects against metabolic degradation, giving a long half-life; it is also stabilized against DPP-4. The mechanism of kidney-related risk reduction has not been established.

Labeled dosing

Adults: initiate at 0.25 mg subcutaneously once weekly for 4 weeks, then 0.5 mg once weekly. If additional glycemic control is needed, increase to 1 mg after at least 4 weeks on 0.5 mg, then to 2 mg after at least 4 weeks on 1 mg. Maximum recommended dose is 2 mg once weekly. In type 2 diabetes with chronic kidney disease, increase to the 1 mg maintenance dose after at least 4 weeks on 0.5 mg. The final dose is determined by the prescriber.

🎓 Key points for students

🩺 Run a clinic or medical center?

EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.

Try EME free   How we protect your data

❓ FAQ

What is Ozempic used for?

In adults with type 2 diabetes it is used to improve blood sugar control alongside diet and exercise, and in specific groups to reduce the risk of heart and kidney complications, as decided by the doctor.

How often is it injected?

Once weekly on the same day each week, at any time of day with or without meals. The dose is set by your doctor or pharmacist.

What should I do if I miss a dose?

Inject it as soon as possible within 5 days of the missed dose. If more than 5 days have passed, skip it and take the next dose on your regular day.

What are the most common side effects?

Nausea, vomiting, diarrhea, abdominal pain, and constipation. Seek medical help right away for severe abdominal pain, allergic symptoms, or a lump in the neck.

Who should not use it?

People with a personal or family history of medullary thyroid carcinoma, those with MEN 2, or those with a serious allergy to semaglutide or any of its ingredients.

Can it be used with insulin?

Yes, but as separate injections that are never mixed. Your insulin dose may need to be reduced to avoid low blood sugar, as decided by your doctor.

⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-07), simplified. Updated: 2026-11-15.